- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)
LivaNova PLC stock price live, this page displays NASDAQ LIVN stock exchange data. View the LIVN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LivaNova PLC real time stock price chart below.
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 63.16.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 63.16.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.45
63.91
52 wk Range
32.48
65.57
LIVN is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.4563.91
52 wk Range
32.4865.57
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIVN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
73.00
Upside
+15.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
- Form 8K LIVANOVA PLC For: 14 January
- Investing.com
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 8K LIVANOVA PLC For: 14 January
- Investing.com
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
LivaNova PLC Company Profile
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
LivaNova PLC SWOT Analysis
Innovation Pipeline | Explore LivaNova's product development strategy, focusing on the Essenz heart-lung machine and potential breakthroughs in sleep apnea and depression treatments |
Market Dynamics | Delve into LivaNova's positioning in the cardiopulmonary and neuromodulation segments, examining competitive pressures and expansion opportunities |
Financial Outlook | Analysts project 6-7% organic growth for LivaNova, with potential to exceed this range. Average price target from analysts stands at $56.50 |
Regulatory Landscape | Uncover the impact of regulatory decisions on LivaNova's growth prospects, including FDA submissions and Medicare coverage reconsiderations |
LivaNova PLC Earnings Call Summary for Q3/2025
- LivaNova exceeded Q3 2025 expectations with EPS of $1.11 (20.65% above forecast) and revenue of $358M, driving a 2.24% pre-market stock increase
- Revenue grew 13% organically with cardiopulmonary segment up 16% and epilepsy segment up 6%, bolstered by the ESSENCE Heart-Lung Machine launch in China
- Financial position strengthened with cash balance increasing to $646M from $429M at end-2024, while total debt reduced to $434M from $628M
- Company raised full-year guidance with organic revenue growth of 9.5-10.5% and adjusted EPS of $3.80-$3.90, despite conservative Q4 outlook
- Management plans continued investment in Obstructive Sleep Apnea and Depression programs, with potential CMS coverage for depression treatment expected in 2026
Last Updated: 2025-11-05, 09:52 a/m
Read Full TranscriptCompare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.9x | 18.8x | −0.6x | |
PEG Ratio | 0.02 | 0.17 | 0.00 | |
Price/Book | 3.0x | 3.0x | 2.6x | |
Price / LTM Sales | 2.6x | 2.7x | 3.4x | |
Upside (Analyst Target) | 10.8% | 24.2% | 41.5% | |
Fair Value Upside | Unlock | 4.1% | 4.4% | Unlock |
Analyst Ratings
9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 73.00
(+15.58% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
1.11 / 0.92
Revenue / Forecast
357.80M / 342.70M
People Also Watch
FAQ
What Is the LivaNova PLC (LIVN) Stock Price Today?
The LivaNova PLC stock price today is 63.16
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Is the LivaNova PLC Market Cap?
As of today, LivaNova PLC market cap is 3.45B.
What Is LivaNova PLC's Earnings Per Share (TTM)?
The LivaNova PLC EPS (TTM) is -3.99.
When Is the Next LivaNova PLC Earnings Date?
LivaNova PLC will release its next earnings report on Feb 25, 2026.
From a Technical Analysis Perspective, Is LIVN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has LivaNova PLC Stock Split?
LivaNova PLC has split 0 times.
How Many Employees Does LivaNova PLC Have?
LivaNova PLC has 2900 employees.
What is the current trading status of LivaNova PLC (LIVN)?
As of Jan 25, 2026, LivaNova PLC (LIVN) is trading at a price of 63.16, with a previous close of 63.88. The stock has fluctuated within a day range of 62.45 to 63.91, while its 52-week range spans from 32.48 to 65.57.
What Is LivaNova PLC (LIVN) Price Target According to Analysts?
The average 12-month price target for LivaNova PLC is USD73.00, with a high estimate of USD86 and a low estimate of USD64. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +15.58% Upside potential.
What Is the LIVN Premarket Price?
LIVN's last pre-market stock price is 65.01. The pre-market share volume is 60.00, and the stock has decreased by 1.13, or 1.77%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.